Novotek Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Novotek şirketinin toplam hissedar öz sermayesi SEK211.0M ve toplam borcu SEK0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla SEK403.2M ve SEK192.2M dir. Novotek 'in FAVÖK'ü SEK52.8M faiz karşılama oranı -121.9 dur. Şirketin SEK109.1M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

Borç/özkaynak oranı

SEK 0

Borç

Faiz karşılama oranı	-121.9x
Nakit	SEK 109.10m
Eşitlik	SEK 211.00m
Toplam yükümlülükler	SEK 192.20m
Toplam varlıklar	SEK 403.20m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Shareholders Will Be Pleased With The Quality of Novotek's (STO:NTEK B) Earnings

Aug 24

Novotek AB (STO:NTEK B) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

Mar 09

Investors Shouldn't Overlook The Favourable Returns On Capital At Novotek (STO:NTEK B)

Nov 17

Here's What Novotek's (STO:NTEK B) Strong Returns On Capital Mean

May 31

Should Novotek AB (STO:NTEK B) Be Part Of Your Dividend Portfolio?

Mar 08

A Look Into Novotek's (STO:NTEK B) Impressive Returns On Capital

Feb 15

Are Strong Financial Prospects The Force That Is Driving The Momentum In Novotek AB's STO:NTEK B) Stock?

Jan 20

We Think Novotek's (STO:NTEK B) Statutory Profit Might Understate Its Earnings Potential

Dec 31

Novotek (STO:NTEK B) Has Gifted Shareholders With A Fantastic 205% Total Return On Their Investment

Dec 10

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: NTEK B 'nin kısa vadeli varlıkları ( SEK227.0M ) kısa vadeli yükümlülüklerini ( SEK162.5M ) aşıyor.

Uzun Vadeli Yükümlülükler: NTEK B şirketinin kısa vadeli varlıkları ( SEK227.0M ) uzun vadeli yükümlülüklerini ( SEK29.7M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: NTEK B borçsuzdur.

Borcun Azaltılması: NTEK B son 5 yıldır borcu bulunmamaktadır.

Borç Kapsamı: NTEK B un borcu yoktur, dolayısıyla işletme nakit akışı tarafından karşılanmasına gerek yoktur.

Faiz Kapsamı: NTEK B şirketinin borcu bulunmadığından faiz ödemelerinin karşılanması söz konusu değildir.

Novotek Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Shareholders Will Be Pleased With The Quality of Novotek's (STO:NTEK B) Earnings

Second quarter 2024 earnings released: EPS: kr0.76 (vs kr0.65 in 2Q 2023)

Now 23% undervalued after recent price drop

First quarter 2024 earnings released: EPS: kr0.93 (vs kr0.66 in 1Q 2023)

Upcoming dividend of kr1.65 per share

Novotek AB (STO:NTEK B) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

Investor sentiment improves as stock rises 16%

Full year 2023 earnings released: EPS: kr3.09 (vs kr2.93 in FY 2022)

Novotek (STO:NTEK B) Could Be Struggling To Allocate Capital

Investor sentiment deteriorates as stock falls 17%

Novotek AB, Annual General Meeting, May 06, 2024

Novotek AB to Report Nine Months, 2024 Results on Nov 07, 2024

Now 22% undervalued

Now 21% undervalued after recent price drop

Second quarter 2023 earnings released: EPS: kr0.65 (vs kr0.52 in 2Q 2022)

Investor sentiment deteriorates as stock falls 15%

Upcoming dividend of kr1.50 per share at 2.5% yield

Now 22% undervalued

Now 20% undervalued

Full year 2022 earnings released: EPS: kr2.93 (vs kr3.75 in FY 2021)

Investor sentiment improves as stock rises 21%

Now 21% undervalued

Novotek AB, Annual General Meeting, May 08, 2023

Novotek AB to Report Nine Months, 2023 Results on Nov 10, 2023

Novotek (STO:NTEK B) Might Become A Compounding Machine

Second quarter 2022 earnings released

Investor sentiment deteriorated over the past week

Novotek AB to Report Fiscal Year 2022 Results on Feb 16, 2023

First quarter 2022 earnings released

Now 24% undervalued after recent price drop

Upcoming dividend of kr1.50 per share

Full year 2021 earnings released: EPS: kr3.75 (vs kr2.68 in FY 2020)

Investor sentiment improved over the past week

Here's What Novotek's (STO:NTEK B) Strong Returns On Capital Mean

Investor sentiment deteriorated over the past week

Now 26% undervalued after recent price drop

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investors Shouldn't Overlook The Favourable Returns On Capital At Novotek (STO:NTEK B)

Third quarter 2021 earnings released

Independent Director recently sold kr620k worth of stock

Novotek AB (OM:NTEK B) acquired 40% stake in TG Alpha for €0.2 million ($0.24 million).

Second quarter 2021 earnings released: EPS kr1.23 (vs kr0.62 in 2Q 2020)

Investor sentiment improved over the past week

Here's What Novotek's (STO:NTEK B) Strong Returns On Capital Mean

Upcoming dividend of kr2.25 per share

Full year 2020 earnings released: EPS kr2.68 (vs kr2.52 in FY 2019)

Should Novotek AB (STO:NTEK B) Be Part Of Your Dividend Portfolio?

New 90-day high: kr48.50

A Look Into Novotek's (STO:NTEK B) Impressive Returns On Capital

New 90-day high: kr47.90

Are Strong Financial Prospects The Force That Is Driving The Momentum In Novotek AB's STO:NTEK B) Stock?

New 90-day high: kr45.80

We Think Novotek's (STO:NTEK B) Statutory Profit Might Understate Its Earnings Potential

New 90-day high: kr44.10

Novotek (STO:NTEK B) Has Gifted Shareholders With A Fantastic 205% Total Return On Their Investment

New 90-day high: kr42.50

Novotek AB to Report Q1, 2021 Results on May 06, 2021

New 90-day high: kr41.50

New 90-day high: kr40.40

New 90-day high - kr40.20

Earnings released

New 90-day high - kr36.20

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin